Moderna Vaccine 96 Per Cent Effective In 12-17 Year-Olds, Study Shows

Moderna said Thursday its Covid-19 vaccine is 96 percent effective among youths aged 12 to 17, according to the results of its first clinical trials.

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!